Bristol-Myers Squibb Co. (BMY): Price and Financial Metrics
BMY Price/Volume Stats
Current price | $57.85 | 52-week high | $81.43 |
Prev. close | $58.04 | 52-week low | $57.15 |
Day low | $57.15 | Volume | 8,864,859 |
Day high | $58.06 | Avg. volume | 9,016,214 |
50-day MA | $60.73 | Dividend yield | 3.92% |
200-day MA | $66.64 | Market Cap | 120.85B |
BMY Stock Price Chart Interactive Chart >
BMY POWR Grades
- Value is the dimension where BMY ranks best; there it ranks ahead of 98.02% of US stocks.
- BMY's strongest trending metric is Growth; it's been moving down over the last 177 days.
- BMY's current lowest rank is in the Momentum metric (where it is better than 3.78% of US stocks).
BMY Stock Summary
- BRISTOL MYERS SQUIBB CO's market capitalization of $123,048,162,047 is ahead of 98.45% of US-listed equities.
- BRISTOL MYERS SQUIBB CO's stock had its IPO on January 1, 1986, making it an older stock than 93.16% of US equities in our set.
- Of note is the ratio of BRISTOL MYERS SQUIBB CO's sales and general administrative expense to its total operating expenses; just 13.32% of US stocks have a lower such ratio.
- Stocks that are quantitatively similar to BMY, based on their financial statements, market capitalization, and price volatility, are GILD, ADI, AMGN, DE, and PFE.
- Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.
BMY Valuation Summary
- BMY's price/sales ratio is 2.7; this is 42.11% higher than that of the median Healthcare stock.
- BMY's price/sales ratio has moved up 0.1 over the prior 243 months.
Below are key valuation metrics over time for BMY.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
BMY | 2023-09-22 | 2.7 | 3.8 | 15.5 | 17.5 |
BMY | 2023-09-21 | 2.7 | 3.9 | 15.5 | 17.6 |
BMY | 2023-09-20 | 2.7 | 3.8 | 15.4 | 17.5 |
BMY | 2023-09-19 | 2.7 | 3.8 | 15.4 | 17.5 |
BMY | 2023-09-18 | 2.7 | 3.8 | 15.4 | 17.5 |
BMY | 2023-09-15 | 2.7 | 3.9 | 15.5 | 17.6 |
BMY Growth Metrics
- The 4 year cash and equivalents growth rate now stands at 304.53%.
- Its 3 year net cashflow from operations growth rate is now at 163.12%.
- The 2 year net cashflow from operations growth rate now stands at 53.2%.

The table below shows BMY's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 46,159 | 13,066 | 6,327 |
2022-09-30 | 46,738 | 13,817 | 6,677 |
2022-06-30 | 47,144 | 15,396 | 6,617 |
2022-03-31 | 46,960 | 16,195 | 6,251 |
2021-12-31 | 46,385 | 16,207 | 6,994 |
2021-09-30 | 45,468 | 15,820 | -5,405 |
BMY's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- BMY has a Quality Grade of B, ranking ahead of 79.64% of graded US stocks.
- BMY's asset turnover comes in at 0.38 -- ranking 124th of 680 Pharmaceutical Products stocks.
- PAHC, ACUR, and XLRN are the stocks whose asset turnover ratios are most correlated with BMY.
The table below shows BMY's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.380 | 0.759 | -0.071 |
2021-03-31 | 0.353 | 0.744 | -0.072 |
2020-12-31 | 0.339 | 0.723 | -0.123 |
2020-09-30 | 0.307 | 0.713 | 0.062 |
2020-06-30 | 0.314 | 0.696 | 0.050 |
2020-03-31 | 0.334 | 0.681 | 0.058 |
BMY Price Target
For more insight on analysts targets of BMY, see our BMY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $80.06 | Average Broker Recommendation | 1.47 (Moderate Buy) |
Bristol-Myers Squibb Co. (BMY) Company Bio
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion. (Source:Wikipedia)
Latest BMY News From Around the Web
Below are the latest news stories about BRISTOL MYERS SQUIBB CO that investors may wish to consider to help them evaluate BMY as an investment opportunity.
Why You Might Be Interested In Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming DividendBristol-Myers Squibb Company ( NYSE:BMY ) is about to trade ex-dividend in the next four days. Typically, the... |
3 Dividend Stocks to Buy and Hold Until RetirementTogether, these stocks can also help diversify your portfolio by giving you exposure to different industries. |
The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is OutThe pharmaceuticals sector is enduring a tough year in the stock market. Companies selling weight-loss drugs are a big exception. |
FDA Accepts Sanofi's (SNY) sBLA for Dupixent in Pediatric EoEIf this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved treatment for eosinophilic esophagitis in children aged 1 to 11. A final decision is expected in January. |
Bristol Myers Squibb to Report Results for Third Quarter 2023 on October 26, 2023PRINCETON, N.J., September 26, 2023--Bristol Myers Squibb to Report Results for Third Quarter 2023 on October 26, 2023 |
BMY Price Returns
1-mo | -6.72% |
3-mo | N/A |
6-mo | -15.72% |
1-year | -15.94% |
3-year | 7.44% |
5-year | 8.07% |
YTD | -17.57% |
2022 | 18.98% |
2021 | 2.88% |
2020 | 0.41% |
2019 | 27.74% |
2018 | -12.90% |
BMY Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching BMY
Here are a few links from around the web to help you further your research on Bristol Myers Squibb Co's stock as an investment opportunity:Bristol Myers Squibb Co (BMY) Stock Price | Nasdaq
Bristol Myers Squibb Co (BMY) Stock Quote, History and News - Yahoo Finance
Bristol Myers Squibb Co (BMY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...